2-(4-Methylphenyl)propanal
Common Name: |
2-(4-Methylphenyl)propanal |
IUPAC Name: |
2-(4-methylphenyl)propanal |
Molecular Formula: |
C10H12O |
SMILES: |
CC1=CC=C(C=C1)C(C)C=O |
Inchi: |
1S/C10H12O/c1-8-3-5-10(6-4-8)9(2)7-11/h3-7,9H,1-2H3 |
Inchi Key: |
JTZWVKUZBNHSSW-UHFFFAOYSA-N |
Cas No: |
99-72-9 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
148.20 |
Mass (g/mol) |
148.089 |
Molar Refractivity |
46.19 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
2 |
Rings |
1 |
TPSA |
17.07 |
Hetero Atoms |
1 |
Heavy Atoms |
11 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
222.00 to 224.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.08 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.30 |
LogP |
2.297 |
iLOGP |
1.84 |
XLOGP3 |
2.26 |
WLOGP |
2.30 |
MLOGP |
2.40 |
ESOL Log S |
-2.45 |
ESOL Solubility (mg/ml) |
0.521 |
ESOL Solubility (mol/l) |
0.004 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.25 |
Ali Solubility (mg/ml) |
0.82 |
Ali Solubility (mol/l) |
0.01 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-3.15 |
Silicos-IT Solubility (mg/ml) |
0.11 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.60 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.892 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.247 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |